Skip to main content
. 2021 Jul 21;9:723490. doi: 10.3389/fbioe.2021.723490

FIGURE 2.

FIGURE 2

The design of hydrogel by altering its physicochemical properties as delivery systems for cancer immunotherapy. (A) Loadable: ensure that the immune cargo can stay in the hydrogel when it does not need to be released. (B) Implantable and injectable: ensure that the hydrogel can reach the tumor site in a minimally invasive, non-surgical way and stays at the tumor site for drug release. (C) Degradable: hydrogel degrades for releasing the encapsulated drugs. (D) Stimulus-responsible: to achieve controlled release of the drugs from hydrogel upon external stimuli.